India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce...
from NDTV News - World-news https://ift.tt/3qY1aOv
No comments:
Post a Comment